Commodity Channel Index
|Bid||172.00 x 900|
|Ask||176.28 x 900|
|Day's Range||173.69 - 179.39|
|52 Week Range||75.17 - 179.39|
|Beta (5Y Monthly)||1.39|
|PE Ratio (TTM)||2,095.42|
|Earnings Date||Jul 29, 2020 - Aug 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||147.25|
Shares of Alteryx (NYSE: AYX) moved higher Wednesday in tandem with other growth stocks as investors kicked off the third quarter on an upbeat note. As a result, the stock closed up 6.7% on Wednesday. Despite a continuing surge in coronavirus cases, investors blew off those concerns and focused on a report from Pfizer that delivered early positive data from an ongoing phase 1/2 trial for a coronavirus vaccine.
Initial public offerings (IPOs) are hot again. And perhaps no company exemplifies this more than ZoomInfo Technologies (NASDAQ:ZI). Prior to this year, very few investors were talking about ZoomInfo, or even were aware of the company. Now, ZI stock is one of the trendiest names around. Shares have more than doubled since they IPOed at $22 on June 4.Source: II.studio / Shutterstock.com Even if you didn't get in at the IPO price, you could still make quick gains. ZoomInfo opened trading at $34 and is now at $50. That's a pretty amazing return inside of a month. It's particularly impressive since this isn't a small company either.At current trading levels, ZoomInfo has a market capitalization of around $20 billion, immediately making it a formidable player in the software-as-a-service space. So what is ZoomInfo, and should you own some?InvestorPlace - Stock Market News, Stock Advice & Trading Tips A Closer Look at ZI StockFrom the company's prospectus, we find that its core mission is to be:"[A] leading go-to-market intelligence platform for sales and marketing teams. Our cloud-based platform provides highly accurate and comprehensive information on the organizations and professionals they target. This "360-degree view" enables sellers and marketers to shorten sales cycles and increase win rates by delivering the right message, to the right person, at the right time, to hit their number."The company points to the considerable success that it has already achieved. At the time of the IPO, ZoomInfo had more than 200,000 paying customers, 630 of these customers spend at least $100,000 per year on the company's software. The company generates revenues entirely from subscriptions, and it estimates that its total addressable market is currently $24 billion per year. * 10 Consumer Stocks to Buy to Ride the Post-Covid-19 Wave More specifically, the company is currently a leader in collecting publicly-available information and organizing it for salespeople. As you know, there's a ton of data, including contact information, on the internet. But much of it isn't well-organized or centrally located. By finding it and assembling it into an easy-to-use package, ZoomInfo gives its clients a big leg-up in their own sales and marketing process.One other important note before we move on. You probably already know this, but just to be clear, there is absolutely no connection between ZoomInfo and Zoom Video (NASDAQ:ZM). They're entirely different businesses, management teams, and capital structures. Anyone buying ZoomInfo thinking it is a video conferencing play is making a mistake. Favorable NumbersThe good news starts at the revenues line. ZoomInfo pulled in nearly $300 million in sales last year. Impressively, that figure more than doubled from 2018's haul.Also, of note, ZoomInfo is already profitable on an operating basis. That's quite rare among new technology IPOs nowadays. That profitability does come with an asterisk. After paying interest on its debt, ZoomInfo was unprofitable last year. However, with the capital it raised from the IPO, ZoomInfo should be able to clean up its balance sheet and further improve its earnings profile.Going forward, the company's growth appears to continue to be on a solid trajectory. The company's revenues should surpass $500 million this year. And the novel coronavirus does not appear to have had a major impact on the business either. If anything, improved sales and marketing spend is even more important right now given the drastic changes in the economy. DrawbacksCompetition is the main concern for ZoomInfo. The company sees its addressable market at $24 billion and its market cap is already up to $20 billion. As such, it needs to secure a large portion of the total addressable market for the investment to be highly-profitable on a long-term basis.However, there are plenty of other rivals that want the same customers. On the more sophisticated end, you have companies like Microsoft's (NASDAQ:MSFT) LinkedIn that have vast quantities of customer data as well. On the low end, it's easy for data scrapers to sell similar data to ZoomInfo, albeit with generally lower quality and a more complicated user experience.Another concern is that ZoomInfo uses multiple classes of stock with different voting rights. As a result, as it stands now, insiders hold 89.6% of the total voting shares of ZoomInfo. In the event that the company started heading in a poor direction, it would be difficult to force insiders to make changes. ZI Stock VerdictAs long as the hot market for software-as-a-service stocks continues, ZoomInfo shares could easily continue powering higher. Valuations -- in particular price/sales multiples -- are hitting record highs across the industry.Compared to other hot names like Fastly (NYSE:FSLY), Zoom Video, and Alteryx (NYSE:AYX), there's more room for near-term gains at ZoomInfo.At some point, however, expect ZoomInfo to take a breather. Remember, the public offering was at $22 and it started trading at $34 just a few weeks ago. At $50, there's already a good chunk of speculative premium built into shares.At this point, the company really needs to get a few more quarters of growth under its belt to back up its valuation.Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. You can reach him on Twitter at @irbezek. At the time of this writing, he held no positions in any of the aforementioned securities. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * America's 1 Stock Picker Reveals His Next 1,000% Winner * Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company * Radical New Battery Could Dismantle Oil Markets The post There Still May Be Money to Be Made as ZoomInfo Stock Powers Higher appeared first on InvestorPlace.
Futures rose Friday after a quietly bullish session for the coronavirus stock market rally. Salesforce and Paylocity broke out Thursday.
The Dow Jones Industrial Average fell but closed well off session lows, as higher-than-expected jobless claims and rising coronavirus fears pressured the market.
The stock market was lower early Thursday on weak jobless data. Breakout stocks to watch include Alteryx, Lam Research and Teradyne.
Dow Jones futures fell even as China said Beijing's Covid-19 outbreak is under control. The market rally hit resistance Wednesday.
On a portfolio-weighted basis, Leaderboard companies delivered a 77% gain from Jan. 1, 2017 to Dec. 31, 2019.
Alteryx, Inc. (NYSE: AYX), a leader in analytic process automation (APA), today introduced new product innovations that deliver the ease-of-use and performance the platform is known for, including Alteryx Analytics Hub, a new product to extend the power and value of the Alteryx APA Platform, and Alteryx Intelligence Suite, a new predictive modeling add-on for Alteryx Designer. Both offerings help fuel rapid digital transformation by delivering on the promise of APA, transforming how businesses leverage their data assets, optimize their processes and upskill talent in a unified, human-centered platform.
Alteryx currently claims only a sliver of that ginormous market. Customers love how easy Alteryx's software makes analyzing large amounts of data. It's not surprising that Alteryx now has more than 6,400 customers across every major industry, including 37% of the Global 2000.
With organizations migrating to cloud computing and other digital operating systems, the need for data analytics has been booming. Helping lead the charge has been Alteryx (NYSE: AYX), a software outfit that helps data analysts and scientists gather and clean up digital information -- what Alteryx calls Analytic Process Automation -- and then make decisions based on it. In the early days of this pandemic, Alteryx has done well; its data automation platform has been in high demand as companies try to adapt to the times.
On CNBC's "Mad Money Lightning Round," Jim Cramer said he's not going to recommend Ares Capital Corporation (NASDAQ: ARCC). He doesn't know what are its investments.UBS Group AG (NYSE: UBS) doesn't have a great dividend, said Cramer. He is not a buyer of the stock. He added that Wells Fargo & Co (NYSE: WFC) has a better dividend. He is starting to warm up again to Wells Fargo because it got out of the auto loan business.Cramer believes in RNA technology and he likes Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT). He sees as a speculative stock and he wouldn't commit a lot of capital to it.Alteryx Inc (NYSE: AYX) is a buy, said Cramer.There is too much heavy lifting for Lyft Inc (NASDAQ: LYFT), with problems in cities and COVID-19, explained Cramer.See more from Benzinga * Cramer Gives His Opinion Alteryx, Johnson & Johnson And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of Alteryx (NYSE: AYX) were climbing again last month as the cloud-based data analytics provider continued to rebound from the stock market crash in March. Alteryx shares actually pulled back briefly after the company's first-quarter earnings report, but rallied later in the month with the help of an analyst upgrade and broader gains among SaaS (software-as-a-service) stocks. According to data from S&P Global Market Intelligence, Alteryx finished last month up 27%.
My view is that IIP should be able to continue its remarkable growth trajectory for years to come. There are two keys for IIP to double an initial investment by mid-2025. First, the company must keep paying a dividend at least at its current level.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
Aside from our house, all the money my wife and I have saved over the last 30-plus years is invested in stocks. At 53 years young, we hold a concentrated investment portfolio that will fund our eventual retirement.
Joe Fahmy joined the podcast this week to discuss leadership in the biotech sector and three tech stocks for your watchlist.
LOS ANGELES, May 18, 2020 -- In an interview with Capital Market Laboratories (CMLviz), chief financial officer of Alteryx (NYSE:AYX) Kevin Rubin had a few clear messages:.
Here are three growth stocks I'd buy right now. In my view, the best stocks to buy are those of companies that are growing fast, have a huge addressable market, and have a clear competitive advantage that should enable them to capture a big chunk of that market. Alteryx provides a cloud-based software platform that enables quick and easy analysis of large amounts of data.
On an "Executive Decision" segment of Mad Money Thursday evening, Jim Cramer spoke with Dean Stoecker, chairman and CEO of Alteryx Inc. , the enterprise software company. Stoecker said that thanks to the pandemic, companies are realizing the importance of data and analytics in their digital transformations. Analytics is playing a big part in Covid-19, Stoecker said, from sequencing the virus's genome to tracking its spread to managing supply chains for critical supplies.
The massive volumes of information being generated and used by businesses today for informed decision making have fueled the booming business of data analytics and Big Data companies.
In a talk with TheStreet, Alteryx CFO Kevin Rubin discussed the COVID-19 pandemic's near-term impact, as well as Alteryx's strategic thinking on R&D; and M&A;.
Alteryx, Inc. (NYSE: AYX) today unveiled its enhanced analytic process automation (APA) platform, which unifies analytics, data science and business process automation in one, end-to-end platform. By bringing data, processes and people together in a converged approach, the Alteryx APA Platform enables high-impact business outcomes and rapid upskilling of people across the organization. Designed to put automation in the hands of all data workers—from line-of-business users to skilled analysts and data scientists—the human-centered platform transforms how businesses leverage their data assets, optimize their processes and upskill human talent to generate workforce efficiencies, top-line growth and optimize costs.